September is designated as “Prostate Cancer Awareness Month”, with various global activities that highlight and increase awareness of prostate cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of prostate cancer, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers can be seen below:

“Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters”
by Piotr Woźnicki, Niklas Westhoff, Thomas Huber, Philipp Riffel, Matthias F. Froelich, Eva Gresser, Jost von Hardenberg, Alexander Mühlberg, Maurice Stephan Michel, Stefan O. Schoenberg et al.
Cancers 2020, 12(7), 1767; https://doi.org/10.3390/cancers12071767
Available online: https://www.mdpi.com/2072-6694/12/7/1767

“Immunotherapy in Prostate Cancer”
by Emily K. Fay and Julie N. Graff
Cancers 2020, 12(7), 1752; https://doi.org/10.3390/cancers12071752
Available online: https://www.mdpi.com/2072-6694/12/7/1752

“The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis”
by Francesco Bonollo, George N. Thalmann, Marianna Kruithof-de Julio and Sofia Karkampouna
Cancers 2020, 12(7), 1887; https://doi.org/10.3390/cancers12071887
Available online: https://www.mdpi.com/2072-6694/12/7/1887

“Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance”
by Maddison Archer, Navneet Dogra and Natasha Kyprianou
Cancers 2020, 12(10), 2984; https://doi.org/10.3390/cancers12102984
Available online: https://www.mdpi.com/2072-6694/12/10/2984

“VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer”
by Daniela Barros-Silva, João Lobo, Catarina Guimarães-Teixeira, Isa Carneiro, Jorge Oliveira, Elena S. Martens-Uzunova, Rui Henrique and Carmen Jerónimo
Cancers 2020, 12(4), 771; https://doi.org/10.3390/cancers12040771
Available online: https://www.mdpi.com/2072-6694/12/4/771

“BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside”
by Stergios Boussios, Elie Rassy, Michele Moschetta, Aruni Ghose, Sola Adeleke, Elisabet Sanchez, Matin Sheriff, Cyrus Chargari and Nicholas Pavlidis
Cancers 2022, 14(16), 3888; https://doi.org/10.3390/cancers14163888
Available online: https://www.mdpi.com/2072-6694/14/16/3888

“Proteomic Analysis of Exosomes for Discovery of Protein Biomarkers for Prostate and Bladder Cancer”
by Yi-Ting Wang, Tujin Shi, Sudhir Srivastava, Jacob Kagan, Tao Liu and Karin D. Rodland
Cancers 2020, 12(9), 2335; https://doi.org/10.3390/cancers12092335
Available online: https://www.mdpi.com/2072-6694/12/9/2335

“Immune Checkpoint Inhibitors in Prostate Cancer”
by Shobi Venkatachalam, Taylor R. McFarland, Neeraj Agarwal and Umang Swami
Cancers 2020, 13(9), 2187; https://doi.org/10.3390/cancers13092187
Available online: https://www.mdpi.com/2072-6694/13/9/2187

“Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer”
by Asta Juzeniene, Vilde Yuli Stenberg, Øyvind Sverre Bruland and Roy Hartvig Larsen
Cancers 2020, 13(4), 779; https://doi.org/10.3390/cancers13040779
Available online: https://www.mdpi.com/2072-6694/13/4/779

“Influence of Intratumor Microbiome on Clinical Outcome and Immune Processes in Prostate Cancer”
by Jiayan Ma, Aditi Gnanasekar, Abby Lee, Wei Tse Li, Martin Haas, Jessica Wang-Rodriguez, Eric Y. Chang, Mahadevan Rajasekaran and Weg M. Ongkeko
Cancers 2020, 12(9), 2524; https://doi.org/10.3390/cancers12092524
Available online: https://www.mdpi.com/2072-6694/12/9/2524

You are welcome to submit relevant papers to the journal Cancers. For more information, contact us at [email protected].

Cancers Editorial Office